Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOMA: Allogeneic Adipose MSCs in Diabetic CLI
NCT04466007Phase 2Completed
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Jan 2021
- Primary completion
- May 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic adipose-derived mesenchymal stromal cells in critical limb ischemia (CLI), sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Started Jan 2021; status: completed.
02
Drugs
allogeneic adipose-derived mesenchymal stromal cells
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT04466007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04466007.